At the news
? NEUTRALIMPACT 2/10 8-K filed May 19, 2026 at 08:37 ET
Lifeward Ltd. announced the appointment of Dr. Keith D. Rose, an internal promotion from VP Medical Affairs to Chief Medical Officer, effective May 1, 2026. This is a routine executive personnel change within a small-cap medtech company with no material financial or operational impact disclosed.
- Appointment of Keith D. Rose, M.D. as Chief Medical Officer effective May 1, 2026
- Dr. Rose has been with Lifeward since March 2023, most recently serving as VP Medical Affairs, Medical Director Neurosciences
- No financial terms, compensation details, or operational changes were disclosed in the filing
- Company market cap is approximately $18M with 88% analyst bullish consensus
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access